ARTICLE | Clinical News
Herceptin trastuzumab anti-HER2 antibody regulatory update
September 3, 2002 7:00 AM UTC
The FDA granted marketing approval to DNA to include information about PathVysion, a fluorescence in-situ hybridization (FISH) assay from Vysis Inc. (Downers Grove, Ill.) on the label for DNA’s Herce...